Vesugen 20mg
Research-grade Vesugen 20mg. 99% purity, third-party tested with published COA.
Ships from USA
1–3 day delivery
Free Shipping
On orders $150+
Peptide Handling & Storage Guide
Storage temperature, shelf life & reconstitution (PDF)
99%+ Purity
COA included
Same-Day Shipping
Orders before 2PM EST
Secure Checkout
SSL encrypted
Shipment Protection
Lost or damaged — reshipped free
Compound Information
- Type
- Synthetic tripeptide bioregulator
- Molecular Formula
- C15H26N4O8
- Molecular Weight
- 390.39 g/mol
- Purity
- 99%
- Sequence
- Lys-Glu-Asp (KED)
Reference chemistry (free base) from public chemical databases and peer-reviewed literature. For laboratory research identification only.
Research Use Only. This vial is bound for the lab bench — supplied for in-vitro scientific work exclusively, never for administration to any person or animal.
About Vesugen
Vesugen corresponds to the tripeptide Lys-Glu-Asp (KED; PubChem CID 87571363, C15H26N4O8, ~390.4 g/mol), one of the ultrashort "peptide bioregulators" developed by V. Kh. Khavinson and colleagues and categorized in that framework as a vascular-tissue peptide.
In cell- and tissue-culture research, KED has been reported to affect proliferation and apoptosis markers (for example, Ki-67 and p53) in organotypic cultures, and in vascular-endothelium models to offset an age-related decline in Ki-67; a molecular-docking study proposed an interaction with the MKI67 gene promoter. All of these findings are preclinical and originate largely from a single research group; they do not establish any effect in humans.
Frequently Asked Questions
What is Vesugen?
Vesugen is a synthetic tripeptide, Lys-Glu-Asp (KED), one of the Khavinson-class short peptide bioregulators. It is supplied as a research-use-only compound and has been studied only in preclinical (in vitro and animal-tissue) research.
What is Vesugen peptide?
It is a three-amino-acid peptide of lysine, glutamic acid, and aspartic acid (Lys-Glu-Asp / KED), molecular formula C15H26N4O8 (~390.4 g/mol; PubChem CID 87571363). In the Khavinson framework it is classed as a vascular-tissue bioregulator.
What is the sequence of Vesugen?
The sequence is Lys-Glu-Asp (lysine–glutamic acid–aspartic acid), commonly abbreviated KED.
What has Vesugen been studied for in the laboratory?
Preclinical studies have examined KED in cell and tissue cultures, reporting effects on markers such as Ki-67 and p53 and a proposed interaction with the MKI67 gene promoter in vascular cell models. These are laboratory findings only, largely from a single research group, and do not establish any effect in humans.
Is Vesugen approved for human use?
No. Vesugen/KED is not approved by any regulator as a drug and is offered strictly for laboratory research use. It is not for human consumption.
Research & References
Independent databases and peer-reviewed literature for Vesugen. Provided for research reference only.
External resources are independent and not affiliated with or endorsed by PHIOGEN. Listed for laboratory research reference only.
